Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    HSP

No quotes available
-- USD   0.00%
2015 ARRAY BIOPHARMA : cfo steps down, replacement named. (BRIEF)
2015 HOSPIRA : A $90 million payday for Hospira CEO after sale to Pfizer
2015 PFIZER : completes acquisition of injectable drugmaker Hospira
 SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensus 
Company
Hospira, Inc. is a pharmaceutical and medication drug delivery company, which engages in providing injectable drugs and infusion technologies.Its portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products.The company... 
Sector
Pharmaceuticals
Calendar
07/27Earnings Release
More about the company
Latest news on HOSPIRA, INC.
2015 ARRAY BIOPHARMA : cfo steps down, replacement named. (BRIEF)
2015 HOSPIRA : A $90 million payday for Hospira CEO after sale to Pfizer
2015 PFIZER : completes acquisition of injectable drugmaker Hospira
2015 HOSPIRA : Termination of a Material Definitive Agreement, Completion of Acquisit..
2015 HOSPIRA : and Cerner Expand Agreement to Advance Integration of I.V.-EMR Technol..
2015 PFIZER : Receives Clearance from U.S. Federal Trade Commission for Hospira Acqui..
2015 HOSPIRA : Announces First Installation of Plum 360 Infusion System With Hospira ..
2015 S&P 500 Plans to Add Activision Blizzard, United Continental Holdings
2015 BRIEF : United Airlines to enter S&P 500, replacing Hospira
2015 PFIZER : Gets Clearance from U.S. FTC for Hospira Acquisition
More news
Sector news : Generic Pharmaceuticals
02:22p BAYER : and Université de Sherbrooke Enter License Agreement to Drive Innovation..
01:47p MERCK KGAA : Professor Frank Stangenberg-Haverkamp receives the "African Allianc..
01:29p NOVO NORDISK A/S : - Share repurchase programme
09:12a NOVO NORDISK A/S : Semaglutide demonstrated superior glycaemic control vs insuli..
09:07a Samsung Bioepis receives final European approval for its Remicade copy
More sector news : Generic Pharmaceuticals
4-Traders Strategies on HOSPIRA, INC. 
2013End of the technical recovery
More Strategies
News from SeekingAlpha
04/19 New Management At ICU Medical Has Produced Positive Results
03/21 PFIZER : 30%+ Discount With 4% Yield
2015 PREMARKET BIOTECH DIGEST : Trouble For Anticoagulants, Gilead U.S. Hep C Sales
2015 Hospira Acquisition To Add Shareholder Value For Pfizer
2015 Activision Blizzard, United Continental set to join S&P 500
Advertisement
Technical analysis trends HOSPIRA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials